Abstract

OBJECTIVES

Our goal was to investigate whether pleural adhesions identified during an operation can induce adverse events. We investigated the outcome of major lung resection in patients with pleural adhesions encountered on entry into the pleural cavity.

METHODS

We conducted a retrospective analysis of 144 patients undergoing major lung resection over a period of 9 months. Recorded data included demographics, comorbidities, surgical data, fluid volume drainage (on postoperative days [POD] 1 and 2 and in total), the overall and pleural space-associated morbidity (empyema, prolonged air leak or drainage, space issues), 30-day and late mortality rates. Patients were grouped according to the presence or not of adhesions observed when we entered the chest.

RESULTS

Differences between patients without versus patients with adhesions were recorded for operative time (138 vs 169.3 min, P < 0.02), postoperative drainage on POD1 and POD2 (328.6 vs 478.5 ml, P < 0.01 and 214 vs 378 ml, P< 0.01 respectively), duration of air leak (1 vs 2 days, P = 0.03), duration of chest tube stay (2 vs 4 days, P < 0.01) and pleural morbidity (21.1% vs 38.8%, P = 0.02). There were no differences recorded in the 2 groups on conversion rates (2.5% vs 14.3%, P = 0.46), 30-day (1.1% vs 4.1%, P = .73) and late deaths (log-rank, P = 0.70). Pleural morbidity differed if the chest tube was removed on or earlier than POD2 (57.9% vs 36.9%, P = 0.02). We also calculated differences between those patients with adhesions involving the lower chest (55.1%) versus the rest of the group and specifically drainage on POD1 and POD2 (540.9 vs 372.1 ml, P < 0.01 and 392.5 vs 261 ml, P = 0.02, respectively) and pleural morbidity (46.4% vs 28.6%, P < 0.01). Logistic regression identified that firm, extensive adhesions, present in the lower third of the pleural cavity, are important predictors of pleural morbidity.

CONCLUSIONS

Patients undergoing major lung resection who have pleural adhesions have an increased incidence of adverse surgical outcomes and higher pleural morbidity.

INTRODUCTION

Under normal conditions, the pleural mesothelium exhibits the ability to recycle fluid through several mechanisms [1, 2]. During inflammation, this ability is lost, leading to the accumulation of pleural fluid [3, 4].

Formation of adhesions is usually the end result of an inflammatory process [5]. Evidence indicates that the presence of adhesions interferes with the postoperative recycling of fluid [6], leading to the decreased ability of the pleura to recycle fluid.

The presence of pleural adhesions adds a technical challenge and increases the risk of conversion to open surgery [7–9]. It correlates with bleeding and prolonged air leak [8, 10–12]. Apart from these observations, it is still unclear whether adhesions interfere with the recovery of operated patients.

The aim of the present study was to compare the outcomes of patients undergoing major lung resections with and without the presence of pleural adhesions observed intraoperatively.

PATIENTS AND METHODS

Study design

We reviewed retrospectively the operative notes from 144 consecutive patients who underwent a major lung resection at our institute (without previous operative procedures in the chest) over a period of 9 months (August 2014–April 2015) associated with the presence of pleural adhesions. Various outcome measures were compared between the patients with and without pleural adhesions. Results from this comparison triggered further investigations into differences in the topography of the adhesions and the timing of the removal of the intercostal chest drain (ICD).

Preoperative management of patients

Patients were referred to our department following discussions at our institute’s multidisciplinary team meeting. A chest computed tomography scan not older than 6 weeks and a positron emission tomography scan were obtained in all patients. Functional operability was determined according to the European guidelines [5]. Additional functional testing such as a cardiopulmonary exercise test or a stair-climbing assessment was performed as needed. Performance status was determined for all patients after assessment of a full medical history and clinical evaluation.

Operational details

Five board qualified general thoracic surgeons who perform an acceptable number of anatomical lung resections per year performed all operations. All video-assisted thoracoscopic surgery (VATS) cases were performed with a bi- or triportal approach.

Postoperative management and follow-up of patients

All patients were managed in a dedicated thoracic ward according to standardized protocols of care including early mobilization, venous thrombosis prophylaxis and chest physiotherapy.

Postoperative pain was controlled with the continuous infusion of local anaesthetics through paravertebral catheters. Additional systemic analgesia was administered to achieve a numeric pain score less than 3 (scale range 0 [no pain] to 10 [unbearable pain]).

A single chest drain was left in situ after all lung resections, connected to a digital drainage system with a standardized removal protocol at <400 ml/day of fluid drainage and <20 ml/min air leak for at least 12 h. Standard postoperative and discharge guidelines were applied to all patients.

Our department’s follow-up protocol included postoperative outpatient consultations at 6 weeks, every 6 months for the first 2 years and annually thereafter for 5 years (depending on the date of the operation and the disease).

Patient data

The parameters investigated, apart from the demographics, included comorbidities smoking habits, performance status, operative data (operative time, length of staples used to complete the fissure, extent and side of resection, VATS or open approach), conversion rates, morbidities, air leak duration, drainage characteristics (fluid drainage at postoperative day [POD] 1 and POD2), duration of insertion of the ICD, number and time after the initial operation of reoperations, length of stay (LOS) in the hospital and the mortality rate (30-day and late deaths).

Overall morbidity was categorized into respiratory (including atelectasis, pneumonia, respiratory failure or acute respiratory distress syndrome), cardiac (including atrial fibrillation, hypotension requiring vasoconstrictors, myocardial infarction or heart failure), pleural (including prolonged air leak, pleural effusion drainage ≥400 ml/day, empyema, presence of persistent pleural pocket or chylothorax), surgical (including technical surgical adverse events such as postoperative bleeding, lung infarction or lung herniation) and variable complications (including all the rest of the types of morbidities i.e. renal or gastrointestinal issues). Thirty-day mortality included deaths during the operation.

Adhesion data

Pleural adhesions were assessed from the operative notes according to the extent of involvement of each lobe surface calculated as a percentage of the total pleural cavity. All patients with adhesions were included in the study. The topography of the adhesions (involving or not involving parts of the lower pleural cavity) and the severity of the adhesions (loose or firm and vascular) were also noted.

Grouping of patients

Patients were divided into 2 main groups with or without pleural adhesions.

Study permission

The study was reviewed and approved by the Research and Innovation Department at Leeds Teaching Hospitals NHS Trust, which waived the need of review by a NHS Research Ethics Committee.

Statistical analysis

Statistical analysis was performed with SPSS version 22.0 (Chicago, IL, USA).

All numerical data were investigated for normality of distribution with the Shapiro–Wilk normality test (normally distributed when P > 0.05) and Q–Q plots (acceptable figures for normality of distributed) and were presented as mean ± standard deviation. Skewed data were presented as the median (lower to higher value). Categorical data were presented as percentages.

Statistical significance was determined with the Student t-test, the Mann–Whitney test (when the P-value with the Levene test was <0.05 and not normally distributed according to previous normality testing), the chi-square test (for 2 × 2 tables: when there were no cells of expected value <5 were calculated, higher than 2 × 2 tables) and the Fisher exact tests (when cells had an expected value of <5). The statistical significant level was set to a P-value < 0.05.

Bivariate correlations were generated with Pearson’s test and were reported as an r value with 95% confidence intervals (CI) apart from the P-value, after applying the bootstrap test at 1000 samples. A typical logistic regression analysis after confirming good fit of data was performed to determine predictors (independent variables) of pleural morbidity (dependent variable based on the previous analysis). Log-rank was used to investigate differences in the Kaplan–Meier survival curves. The last date investigated for survival was 20 May 2016.

RESULTS

Main characteristics

During the study period, a major lung resection was performed on 95 (66%) patients without adhesions and 49 (34%) patients with adhesions. There were 62 male patients (43.1%) and 102 smokers or ex-smokers (70.8%). A performance status of 0 and 1 was recorded in 133 (91.3%) patients. A lobectomy was performed in 134 patients (93.1%), a pneumonectomy in 3 (2.1%) and a bilobectomy in 7 (4.9%) patients. A right-sided operation was performed in 80 (55.6%) patients. VATS was the main approach (114 patients, 79.2%) with a conversion rate of 6.14% (for the study period) and of no attribution to the presence of adhesions.

In 36 (73.5%) patients, the adhesions were firm; in 30 patients (61.2%) these were divided with an energy device or diathermy. Extrapleural dissection was necessary in 5 cases. The mean percentage of area occupied by adhesions was 43.47 ± 20.5 (lowest value: 20%, highest value: 90%).

Nine patients were excluded from the study because of incomplete data on the presence of adhesions. None of the patients required intraoperative or postoperative blood transfusions.

Comparison of the 2 groups

The 2 groups were similar in terms of age, co-morbidities, preoperative pulmonary function, performance status, smoking habit, disease stage and body mass index (Table 1). The approach, the extent and the type of the resections were also similar between the 2 groups (Table 1).

Table 1:

Patient and operative characteristics based on the presence of adhesions when the pleural cavity is first entered

No adhesions present (n = 95)Presence of adhesions (n = 49)P-value
Age in years (mean ± SD)69.2 ± 9.269.6 ± 10.10.838a
Gender (n, %)
 Male33 (34.7)29 (59.2)0.126b
 Female62 (65.3)20 (40.8)
Pulmonary function (mean ± SD)
 FEV187.9 ± 26.980.5 ± 30.50.103a
 DLCO66.9 ± 26.660.9 ± 24.40.178a
ASA status (median, lower–higher)2 (1–3)2 (1–3)0.998c
Smoking habit (n, %)
 Smokers/ex-smokers66 (69.5)36 (73.5)0.383b
 Non-smokers29 (30.5)13 (26.5)
Disease stage (n, %)
 I33 (34.7)19 (38.8)0.510b
 II35 (36.8)24 (49)
 >II8 (8.4)2 (4.1)
 Metastatic, benign19 (28.4)4 (8.2)
Comorbidities (n, %)
 Respiratory62 (65.3)32 (65.3)0.266b
 Cardiac13 (13.7)8 (16.3)
 Other20 (21.1)9 (18.4)
BMI in kg/m2 (mean ± SD)30.2 ± 15.428.9 ± 14.20.985a
VATS approach (n, %)79 (83.2)35 (71.4)0.130b
Extend of resection (n, %)
 Lobectomy86480.186b
 Pneumonectomy30
 Bilobectomy61
Lobectomy type (n, %)
 Upper53 (55.8)30 (61.2)0.838b
 Lower31 (32.6)16 (32.6)
 Middle2 (2.1)2 (4.1)
No adhesions present (n = 95)Presence of adhesions (n = 49)P-value
Age in years (mean ± SD)69.2 ± 9.269.6 ± 10.10.838a
Gender (n, %)
 Male33 (34.7)29 (59.2)0.126b
 Female62 (65.3)20 (40.8)
Pulmonary function (mean ± SD)
 FEV187.9 ± 26.980.5 ± 30.50.103a
 DLCO66.9 ± 26.660.9 ± 24.40.178a
ASA status (median, lower–higher)2 (1–3)2 (1–3)0.998c
Smoking habit (n, %)
 Smokers/ex-smokers66 (69.5)36 (73.5)0.383b
 Non-smokers29 (30.5)13 (26.5)
Disease stage (n, %)
 I33 (34.7)19 (38.8)0.510b
 II35 (36.8)24 (49)
 >II8 (8.4)2 (4.1)
 Metastatic, benign19 (28.4)4 (8.2)
Comorbidities (n, %)
 Respiratory62 (65.3)32 (65.3)0.266b
 Cardiac13 (13.7)8 (16.3)
 Other20 (21.1)9 (18.4)
BMI in kg/m2 (mean ± SD)30.2 ± 15.428.9 ± 14.20.985a
VATS approach (n, %)79 (83.2)35 (71.4)0.130b
Extend of resection (n, %)
 Lobectomy86480.186b
 Pneumonectomy30
 Bilobectomy61
Lobectomy type (n, %)
 Upper53 (55.8)30 (61.2)0.838b
 Lower31 (32.6)16 (32.6)
 Middle2 (2.1)2 (4.1)
a

Student t-test.

b

Chi-square test.

c

Mann–Whitney test.

SD: standard deviation; FEV1: forced expiratory volume in the first second; DLCO: diffusing capacity of the lungs for carbon monoxide; ASA: American Society of Anesthesiologists; BMI: body mass index; VATS: video-assisted thoracoscopic surgery.

Table 1:

Patient and operative characteristics based on the presence of adhesions when the pleural cavity is first entered

No adhesions present (n = 95)Presence of adhesions (n = 49)P-value
Age in years (mean ± SD)69.2 ± 9.269.6 ± 10.10.838a
Gender (n, %)
 Male33 (34.7)29 (59.2)0.126b
 Female62 (65.3)20 (40.8)
Pulmonary function (mean ± SD)
 FEV187.9 ± 26.980.5 ± 30.50.103a
 DLCO66.9 ± 26.660.9 ± 24.40.178a
ASA status (median, lower–higher)2 (1–3)2 (1–3)0.998c
Smoking habit (n, %)
 Smokers/ex-smokers66 (69.5)36 (73.5)0.383b
 Non-smokers29 (30.5)13 (26.5)
Disease stage (n, %)
 I33 (34.7)19 (38.8)0.510b
 II35 (36.8)24 (49)
 >II8 (8.4)2 (4.1)
 Metastatic, benign19 (28.4)4 (8.2)
Comorbidities (n, %)
 Respiratory62 (65.3)32 (65.3)0.266b
 Cardiac13 (13.7)8 (16.3)
 Other20 (21.1)9 (18.4)
BMI in kg/m2 (mean ± SD)30.2 ± 15.428.9 ± 14.20.985a
VATS approach (n, %)79 (83.2)35 (71.4)0.130b
Extend of resection (n, %)
 Lobectomy86480.186b
 Pneumonectomy30
 Bilobectomy61
Lobectomy type (n, %)
 Upper53 (55.8)30 (61.2)0.838b
 Lower31 (32.6)16 (32.6)
 Middle2 (2.1)2 (4.1)
No adhesions present (n = 95)Presence of adhesions (n = 49)P-value
Age in years (mean ± SD)69.2 ± 9.269.6 ± 10.10.838a
Gender (n, %)
 Male33 (34.7)29 (59.2)0.126b
 Female62 (65.3)20 (40.8)
Pulmonary function (mean ± SD)
 FEV187.9 ± 26.980.5 ± 30.50.103a
 DLCO66.9 ± 26.660.9 ± 24.40.178a
ASA status (median, lower–higher)2 (1–3)2 (1–3)0.998c
Smoking habit (n, %)
 Smokers/ex-smokers66 (69.5)36 (73.5)0.383b
 Non-smokers29 (30.5)13 (26.5)
Disease stage (n, %)
 I33 (34.7)19 (38.8)0.510b
 II35 (36.8)24 (49)
 >II8 (8.4)2 (4.1)
 Metastatic, benign19 (28.4)4 (8.2)
Comorbidities (n, %)
 Respiratory62 (65.3)32 (65.3)0.266b
 Cardiac13 (13.7)8 (16.3)
 Other20 (21.1)9 (18.4)
BMI in kg/m2 (mean ± SD)30.2 ± 15.428.9 ± 14.20.985a
VATS approach (n, %)79 (83.2)35 (71.4)0.130b
Extend of resection (n, %)
 Lobectomy86480.186b
 Pneumonectomy30
 Bilobectomy61
Lobectomy type (n, %)
 Upper53 (55.8)30 (61.2)0.838b
 Lower31 (32.6)16 (32.6)
 Middle2 (2.1)2 (4.1)
a

Student t-test.

b

Chi-square test.

c

Mann–Whitney test.

SD: standard deviation; FEV1: forced expiratory volume in the first second; DLCO: diffusing capacity of the lungs for carbon monoxide; ASA: American Society of Anesthesiologists; BMI: body mass index; VATS: video-assisted thoracoscopic surgery.

The duration of the operation, as expected, was longer in the group with adhesions (P < 0.01), and more staples were used overall (P < 0.01) in this group (Table 2).

Table 2:

Surgical data and outcomes according to the presence of adhesions when the pleural cavity is first entered

No adhesions present (n = 95)Presence of adhesions (n = 49)P-value
Operative time, min (mean ± SD)138 ± 54.6169.3 ± 61.2<0.001a
Staple length, mm (mean ± SD)145.5 ± 95174 ± 61.2<0.001a
Drainage POD1, ml (mean ± SD)328.6 ± 220.7478.5 ± 232.8<0.001a
Drainage POD2, ml (mean ± SD)214.6 ± 167.8338.5 ± 212.3<0.001a
ICD insertion, days (median, lower–higher)2 (0–15)4 (0–26)<0.001b
Air leak duration, days (median, lower–higher)1 (0–15)2 (0–26)0.026b
Conversions (n, %VATS)2 (2.5)5 (14.3)0.461c
Reoperations (n, %)8 (8.4)9 (18.4)0.052d
Time after initial operation in days (median, lowest–highest)17 (5–30)13.5 (2–90)0.541b
LOS in hospital (median, lower–higher)5 (3–24)7 (4–23)0.003b
Morbidity (n, %)
 Overall43 (45.3)25 (51.0)0.599d
 Pleural20 (21.1)19 (38.8)0.016d
 Effusion/empyema4100.038d
 Prolonged air leak148
 Space/chylothorax21
30-Day mortality rate (n, %)1 (1.1)2 (4.1)0.733c
No adhesions present (n = 95)Presence of adhesions (n = 49)P-value
Operative time, min (mean ± SD)138 ± 54.6169.3 ± 61.2<0.001a
Staple length, mm (mean ± SD)145.5 ± 95174 ± 61.2<0.001a
Drainage POD1, ml (mean ± SD)328.6 ± 220.7478.5 ± 232.8<0.001a
Drainage POD2, ml (mean ± SD)214.6 ± 167.8338.5 ± 212.3<0.001a
ICD insertion, days (median, lower–higher)2 (0–15)4 (0–26)<0.001b
Air leak duration, days (median, lower–higher)1 (0–15)2 (0–26)0.026b
Conversions (n, %VATS)2 (2.5)5 (14.3)0.461c
Reoperations (n, %)8 (8.4)9 (18.4)0.052d
Time after initial operation in days (median, lowest–highest)17 (5–30)13.5 (2–90)0.541b
LOS in hospital (median, lower–higher)5 (3–24)7 (4–23)0.003b
Morbidity (n, %)
 Overall43 (45.3)25 (51.0)0.599d
 Pleural20 (21.1)19 (38.8)0.016d
 Effusion/empyema4100.038d
 Prolonged air leak148
 Space/chylothorax21
30-Day mortality rate (n, %)1 (1.1)2 (4.1)0.733c
a

Student t-test.

b

Mann–Whitney test.

c

Fisher exact test.

d

Chi-square test.

SD: standard deviation; POD: postoperative day; ICD: intercostal chest drain; VATS: video-assisted thoracoscopic surgery; LOS: length of stay.

Table 2:

Surgical data and outcomes according to the presence of adhesions when the pleural cavity is first entered

No adhesions present (n = 95)Presence of adhesions (n = 49)P-value
Operative time, min (mean ± SD)138 ± 54.6169.3 ± 61.2<0.001a
Staple length, mm (mean ± SD)145.5 ± 95174 ± 61.2<0.001a
Drainage POD1, ml (mean ± SD)328.6 ± 220.7478.5 ± 232.8<0.001a
Drainage POD2, ml (mean ± SD)214.6 ± 167.8338.5 ± 212.3<0.001a
ICD insertion, days (median, lower–higher)2 (0–15)4 (0–26)<0.001b
Air leak duration, days (median, lower–higher)1 (0–15)2 (0–26)0.026b
Conversions (n, %VATS)2 (2.5)5 (14.3)0.461c
Reoperations (n, %)8 (8.4)9 (18.4)0.052d
Time after initial operation in days (median, lowest–highest)17 (5–30)13.5 (2–90)0.541b
LOS in hospital (median, lower–higher)5 (3–24)7 (4–23)0.003b
Morbidity (n, %)
 Overall43 (45.3)25 (51.0)0.599d
 Pleural20 (21.1)19 (38.8)0.016d
 Effusion/empyema4100.038d
 Prolonged air leak148
 Space/chylothorax21
30-Day mortality rate (n, %)1 (1.1)2 (4.1)0.733c
No adhesions present (n = 95)Presence of adhesions (n = 49)P-value
Operative time, min (mean ± SD)138 ± 54.6169.3 ± 61.2<0.001a
Staple length, mm (mean ± SD)145.5 ± 95174 ± 61.2<0.001a
Drainage POD1, ml (mean ± SD)328.6 ± 220.7478.5 ± 232.8<0.001a
Drainage POD2, ml (mean ± SD)214.6 ± 167.8338.5 ± 212.3<0.001a
ICD insertion, days (median, lower–higher)2 (0–15)4 (0–26)<0.001b
Air leak duration, days (median, lower–higher)1 (0–15)2 (0–26)0.026b
Conversions (n, %VATS)2 (2.5)5 (14.3)0.461c
Reoperations (n, %)8 (8.4)9 (18.4)0.052d
Time after initial operation in days (median, lowest–highest)17 (5–30)13.5 (2–90)0.541b
LOS in hospital (median, lower–higher)5 (3–24)7 (4–23)0.003b
Morbidity (n, %)
 Overall43 (45.3)25 (51.0)0.599d
 Pleural20 (21.1)19 (38.8)0.016d
 Effusion/empyema4100.038d
 Prolonged air leak148
 Space/chylothorax21
30-Day mortality rate (n, %)1 (1.1)2 (4.1)0.733c
a

Student t-test.

b

Mann–Whitney test.

c

Fisher exact test.

d

Chi-square test.

SD: standard deviation; POD: postoperative day; ICD: intercostal chest drain; VATS: video-assisted thoracoscopic surgery; LOS: length of stay.

Table 3:

Surgical data and outcomes according to the topography of adhesions in the pleural cavity

Not involving lower parts (n = 21)Involving lower parts (n = 28)P-value
Operative time, min (mean ± SD)156.4 ± 49.2178.2 ± 68.60.223a
Stapler length, mm (mean ± SD)202.4 ± 100.7188.4 ± 105.20.177a
Drainage on POD1, ml (mean ± SD)372.1 ± 168.1540.9 ± 250.30.007a
Drainage on POD2, ml (mean ± SD)261.8 ± 137.2392.5 ± 239.80.018a
ICD insertion, days (median, lower–higher)3 (2–21)3 (2–26)0.778b
Air leak duration in days (median, lower–higher)2 (0–21)2 (0–26)0.564b
Conversions (n, %VATS)1 (5.5)4 (23.5)0.031c
Reoperations (n, %)4 (19)5 (17.9)0.600c
Time after initial operation in days (median, lowest–highest)47 (17–90)5 (2–45)0.061b
LOS in hospital (median, lower–higher)6 (4–22)7 (4–23)0.299b
Morbidity (n, %)
 Overall11 (52.4)14 (50)0.599d
 Pleural6 (28.6)13 (46.4)0.005d
 Effusion/empyema190.055d
 Prolonged air leak53
 Space/chylothorax01
30-Day mortality rate (n, %)1 (4.8)1 (3.6)0.571c
Not involving lower parts (n = 21)Involving lower parts (n = 28)P-value
Operative time, min (mean ± SD)156.4 ± 49.2178.2 ± 68.60.223a
Stapler length, mm (mean ± SD)202.4 ± 100.7188.4 ± 105.20.177a
Drainage on POD1, ml (mean ± SD)372.1 ± 168.1540.9 ± 250.30.007a
Drainage on POD2, ml (mean ± SD)261.8 ± 137.2392.5 ± 239.80.018a
ICD insertion, days (median, lower–higher)3 (2–21)3 (2–26)0.778b
Air leak duration in days (median, lower–higher)2 (0–21)2 (0–26)0.564b
Conversions (n, %VATS)1 (5.5)4 (23.5)0.031c
Reoperations (n, %)4 (19)5 (17.9)0.600c
Time after initial operation in days (median, lowest–highest)47 (17–90)5 (2–45)0.061b
LOS in hospital (median, lower–higher)6 (4–22)7 (4–23)0.299b
Morbidity (n, %)
 Overall11 (52.4)14 (50)0.599d
 Pleural6 (28.6)13 (46.4)0.005d
 Effusion/empyema190.055d
 Prolonged air leak53
 Space/chylothorax01
30-Day mortality rate (n, %)1 (4.8)1 (3.6)0.571c
a

Student t-test.

b

Mann–Whitney test.

c

Fisher exact test.

d

Chi-square test.

SD: standard deviation; POD: postoperative day; ICD: intercostal chest drain; VATS: video-assisted thoracoscopic surgery; LOS: length of stay.

Table 3:

Surgical data and outcomes according to the topography of adhesions in the pleural cavity

Not involving lower parts (n = 21)Involving lower parts (n = 28)P-value
Operative time, min (mean ± SD)156.4 ± 49.2178.2 ± 68.60.223a
Stapler length, mm (mean ± SD)202.4 ± 100.7188.4 ± 105.20.177a
Drainage on POD1, ml (mean ± SD)372.1 ± 168.1540.9 ± 250.30.007a
Drainage on POD2, ml (mean ± SD)261.8 ± 137.2392.5 ± 239.80.018a
ICD insertion, days (median, lower–higher)3 (2–21)3 (2–26)0.778b
Air leak duration in days (median, lower–higher)2 (0–21)2 (0–26)0.564b
Conversions (n, %VATS)1 (5.5)4 (23.5)0.031c
Reoperations (n, %)4 (19)5 (17.9)0.600c
Time after initial operation in days (median, lowest–highest)47 (17–90)5 (2–45)0.061b
LOS in hospital (median, lower–higher)6 (4–22)7 (4–23)0.299b
Morbidity (n, %)
 Overall11 (52.4)14 (50)0.599d
 Pleural6 (28.6)13 (46.4)0.005d
 Effusion/empyema190.055d
 Prolonged air leak53
 Space/chylothorax01
30-Day mortality rate (n, %)1 (4.8)1 (3.6)0.571c
Not involving lower parts (n = 21)Involving lower parts (n = 28)P-value
Operative time, min (mean ± SD)156.4 ± 49.2178.2 ± 68.60.223a
Stapler length, mm (mean ± SD)202.4 ± 100.7188.4 ± 105.20.177a
Drainage on POD1, ml (mean ± SD)372.1 ± 168.1540.9 ± 250.30.007a
Drainage on POD2, ml (mean ± SD)261.8 ± 137.2392.5 ± 239.80.018a
ICD insertion, days (median, lower–higher)3 (2–21)3 (2–26)0.778b
Air leak duration in days (median, lower–higher)2 (0–21)2 (0–26)0.564b
Conversions (n, %VATS)1 (5.5)4 (23.5)0.031c
Reoperations (n, %)4 (19)5 (17.9)0.600c
Time after initial operation in days (median, lowest–highest)47 (17–90)5 (2–45)0.061b
LOS in hospital (median, lower–higher)6 (4–22)7 (4–23)0.299b
Morbidity (n, %)
 Overall11 (52.4)14 (50)0.599d
 Pleural6 (28.6)13 (46.4)0.005d
 Effusion/empyema190.055d
 Prolonged air leak53
 Space/chylothorax01
30-Day mortality rate (n, %)1 (4.8)1 (3.6)0.571c
a

Student t-test.

b

Mann–Whitney test.

c

Fisher exact test.

d

Chi-square test.

SD: standard deviation; POD: postoperative day; ICD: intercostal chest drain; VATS: video-assisted thoracoscopic surgery; LOS: length of stay.

The amount of fluid drainage was higher in the group with adhesions on POD1 (P < 0.01) and POD2 (P < 0.01). The duration of the air leak was also longer in the group with adhesions (P = 0.03), and the ICD was removed after a longer period of time in the group with adhesions (P < 0.01).

The overall morbidity was similar between the 2 groups; however, more pleural complications were noted in the group with adhesions (P = 0.02). High fluid drainage was the main cause of pleural-related morbidity in this group, whereas a prolonged air leak was the reason in the group without adhesions (P = 0.04).

More reoperations in total were observed in the group with adhesions (P = 0.052). The main reason for this finding was the presence of persistent pleural space (3 cases) with or without suspected pleural space infection; 1 case required reoperation for postoperative bleeding; 1 for chylothorax; 1 for lung infarction and 1 for a prolonged air leak. In the non-adhesion group, reoperations were necessary in 4 cases with remaining pleural pockets with or without suspected pleural infection: 1 case with prolonged air leak, 2 cases with postoperative bleeding and 1 case with lung herniation. No bronchopleural fistulas were noted. The timing of reoperations was similar in the 2 groups (Table 2).

Despite the fact that a significant conversion rate was noted in the group with adhesions (14%), the conversion rate between the 2 groups was similar (P= 0.46). Conversions included 3 cases of bleeding and 2 cases of inability to excise the tumour completely in the non-adhesion group. The same causes necessitated conversions in the adhesion group. No conversion was necessary due to the presence of adhesions.

The in-hospital LOS was longer in the group with adhesions (P< 0.01).

There was no difference in the 30-day mortality rate (P= 0.73). Two patients with adhesions died of chest infections whereas 1 patient in the non-adhesion group died of acute respiratory distress syndrome.

Bivariate correlations showed a positive correlation between the presence of adhesions and effusion on POD1 (0.280, P < 0.01, CI: 0.139–0.428) and POD2 (0.287, P < 0.01, CI: 0.134–0.429), the duration of air leaks (0.186, P < 0.01, CI: 0.077–0.429), length of time the ICD was inserted (0.270, P < 0.01, CI: 0.120–0.419) and pleural complications (0.186, P = 0.03, CI: 0.017–0.350).

Outcome according to the topography of the adhesions

In the group with adhesions, the amount of fluid drainage was higher on POD1 (P < 0.01) and POD2 (P = 0.01) when the adhesions involved the lower part of the pleural cavity (Table 3).

The overall morbidity was similar between the 2 groups; however, more pleural complications were noted when the adhesions involved the lower pleural cavity (P < 0.01). Again, the pleural morbidity was expressed as prolonged pleural effusion drainage rather than a prolonged air leak (P = 0.055).

In this subgroup, more conversions were noted (23.5% vs 5.5%, P = 0.03). The necessity for reoperation was similar between the 2 groups, but in the group in which the lower pleural cavity was affected, the operation was performed in a more expeditious manner.

In-hospital LOS and the 30-day mortality rates were similar, irrespective of the topography of the adhesion.

Bivariate correlations showed a positive correlation between the presence of adhesions over the lower pleural cavity and effusion on POD1 (0.363, P < 0.01, CI: 0.109–0.551), POD2 (0.316, P = 0.03, CI: 0.103–0.503) and the length of time the ICD was inserted (0.359, P = 0.02, CI: 0.207–0.319).

Timing of ICD removal on the outcome of patients with adhesions

Based on the aforementioned findings, further analysis was performed to identify the appropriate timing for removal of the ICD from these patients. For this reason, we initially performed a receiver operating characteristic analysis in the group with adhesions. The target point was the pleural morbidity, and the predictor test was the length of time the ICD was in place (area under the curve = 0.788) (CI: 0.611–0.924, P =0.002). A cut-off point of 2.5 days for ICD removal was calculated to have 78% sensitivity and 75% specificity for prediction of pleural morbidity.

Further analysis (Table 4

Table 4:

Outcome of patients according to timing of removal of intercostal chest drain

≤2.5 days (n = 19)>2.5 days (n = 30)P-value
Morbidity (n, %)
 Overall14 (73.7)11 (36.7)0.030a
 Pleural11 (57.9)8 (26.7)0.040a
Reoperations (n, %)4 (21.1)5 (16.7)0.221b
LOS in hospital, days (median, lower–higher)7 (4–23)5 (4–22)0.035c
30-Day mortality rate (n, %)1 (5.2)1 (3.3)0.683b
≤2.5 days (n = 19)>2.5 days (n = 30)P-value
Morbidity (n, %)
 Overall14 (73.7)11 (36.7)0.030a
 Pleural11 (57.9)8 (26.7)0.040a
Reoperations (n, %)4 (21.1)5 (16.7)0.221b
LOS in hospital, days (median, lower–higher)7 (4–23)5 (4–22)0.035c
30-Day mortality rate (n, %)1 (5.2)1 (3.3)0.683b
a

Chi-square test.

b

Fisher exact test.

c

Mann–Whitney test.

LOS: length of stay.

Table 4:

Outcome of patients according to timing of removal of intercostal chest drain

≤2.5 days (n = 19)>2.5 days (n = 30)P-value
Morbidity (n, %)
 Overall14 (73.7)11 (36.7)0.030a
 Pleural11 (57.9)8 (26.7)0.040a
Reoperations (n, %)4 (21.1)5 (16.7)0.221b
LOS in hospital, days (median, lower–higher)7 (4–23)5 (4–22)0.035c
30-Day mortality rate (n, %)1 (5.2)1 (3.3)0.683b
≤2.5 days (n = 19)>2.5 days (n = 30)P-value
Morbidity (n, %)
 Overall14 (73.7)11 (36.7)0.030a
 Pleural11 (57.9)8 (26.7)0.040a
Reoperations (n, %)4 (21.1)5 (16.7)0.221b
LOS in hospital, days (median, lower–higher)7 (4–23)5 (4–22)0.035c
30-Day mortality rate (n, %)1 (5.2)1 (3.3)0.683b
a

Chi-square test.

b

Fisher exact test.

c

Mann–Whitney test.

LOS: length of stay.

) of outcomes in patients whose ICD was removed ≤2.5 days compared to patients whose ICD was removed >2.5 days showed that more overall and pleural complications (P = 0.03 and P = 0.04, respectively) as well as longer in-hospital LOS (P = 0.02) were noted in the group whose ICDs were removed early.

Independent predictors of pleural morbidity in patients with adhesions

The type of adhesion (firm) was the most important predictor (P = 0.019, Exp(B) = 4.353, 95% CI 1.686–27.633) followed by the topography (involving the lower chest) of the adhesions (P = 00.043, Exp(B) = 1.439, 95% CI 1.009–6.700) and the extent (%) of the adhesions in the chest (P = 0.037, Exp(B) = 1.008, 95% CI 1.002–1.037) in the model with a Cox and Snell R2 = 0.59, Nagelkerke R2 = 0.65 and the Hosmer and Lemeshow test P = 0.76.

Survival

Survivorship was not affected by the presence of adhesions (Fig. 1). Late deaths were attributed to the progression of the cancer. In 1 case, the patient committed suicide 6 months after the operation.

Kaplan–Meier survival curves of patients with and without adhesions when the pleural cavity is first entered.
Figure 1:

Kaplan–Meier survival curves of patients with and without adhesions when the pleural cavity is first entered.

DISCUSSION

The main finding of our present study is that the presence of pleural adhesions during major lung resections may predict increased pleural fluid drainage on POD1 and POD2, air leak duration, ICD insertion, in-hospital LOS and pleural morbidity. Early chest tube removal (<POD2) in these patients should be carefully reconsidered.

Additionally, apart from the expected prolonged operating time, more reoperations are necessary, although conversion rates are statistically similar and the conversions are performed irrespective of the presence of adhesions.

In our study, a large number of patients with adhesions were operated on, suggesting that adhesions are not an uncommon finding. The operative outcome was worse if adhesions involved the lower pleural cavity, with increased pleural complications, greater amount of pleural fluid drainage and longer ICD insertion. Based on the regression model, extensive, firm adhesions occupying the lower chest are predictive of increased pleural morbidity.

It is widely perceived that when pleural adhesions are encountered when the surgeon enters the chest, the surgeon should be prepared for a technically more demanding operation. Dense pleural adhesions have been considered an absolute contraindication to VATS lobectomy [8, 13, 14], although this concern has been questioned as expertise with VATS procedures has increased [7, 15]. In our study, no conversions were performed because of adhesions, suggesting the technical feasibility of a VATS lobectomy in their presence.

Caution is urged by the authors of published series of patients found with adhesions during thoracoscopic lobectomies mainly due to the increased possibility of bleeding or prolonged air leak or to the increased rate of conversion in this group of patients [10–12, 16]. Traditionally, the operative time is expected to be longer [7]. Minimal data on the outcome of patients, linking adhesions with adverse events either intraoperatively or postoperatively after conversion to thoracotomy, have been reported, without focusing on patients with adhesions per se [7, 9, 13].

The findings of this study confirm those of previously published studies on the functional processes within the pleural space at the clinical practice level. According to these findings, the mesothelial pleural cells exhibit the ability to recycle fluid through active cellular transportation. This ability is limited by the presence of adhesions [6]. Therefore, we have proved at the clinical level that patients with adhesions have decreased pleural fluid perfusion and consequently will experience increased fluid drainage, prolonged ICD insertion time and morbidity. The risk is further increased in those in whom the adhesions occupy the lower parts of the pleural cavity [17].

Another finding of our study was the increased number of staples required to complete the fissure in patients with adhesions. Common sense dictates that the fissures in these patients are less discrete because the inflammatory response responsible for the adhesions does not spare the visceral pleura within the fissure.

Adhesions range from single films of connective tissue easily and bluntly transected to thick ridges of fibrous tissue with vessels and nerves needing sharp dissection and ligation. It has not been studied whether different types of adhesions in the pleural cavity correlate with the severity and extent of the inflammatory insult that occurred. The extent and the macroscopic appearance were previously used to classify peritoneal adhesions in an effort to provide a common language among surgeons [18, 19]. However, these classification systems have not been widely implemented, and surgeons still report adhesions according to their experience and capability. This practice, unfortunately, applies to pleural adhesions as well. Therefore, we have not yet produced a sound grading system for adhesions with clinical significance. A system that will alert surgeons and patients to possible postoperative events and provide tailor-made postoperative management in this group of patients is needed.

Limitations

This study has several limitations. First, it is a single-institution study. Second, all adhesions were reported on the basis of a subjective calculation of the area of coverage as mentioned in the operative notes. Third, the grouping was based on the assumption that different diseases affect the pleural cavity diffusely [20]. Finally, our cohort was relatively small; a larger multi-institutional study is needed.

CONCLUSION

In conclusion, the presence of pleural adhesions in patients undergoing major lung resection can be used to predict postoperative complications, especially adhesions involving the lower part of the pleural cavity. Early removal of chest drains in these patients should be discouraged. Our study calls for an internationally accepted description and grading system from the community of thoracic surgeons of pleural adhesions found during the operation. Such a system would provide a model for predicting postoperative complications and encourage the tailor-made postoperative management of patients with pleural adhesions.

Conflict of interest: none declared.

REFERENCES

1

Lai-Fook
SJ.
Pleural mechanics and fluid exchange
.
Physiol Rev
2004
;
84
:
385
410
.

2

Kouritas
VK
,
Hatzoglou
C
,
Ioannou
M
,
Gourgoulianis
KI
,
Molyvdas
PA.
Insulin alters the permeability of sheep pleura
.
Exp Clin Endocrinol Diabetes
2010
;
118
:
304
9
.

3

Kouritas
VK
,
Tsantsaridou
A
,
Tepetes
K
,
Tsilimingas
N
,
Gourgoulianis
KI
,
Molyvdas
PA
et al.
Effect of histamine on the electrophysiology of the human parietal pleura
.
Mol Cell Endocrinol
2011
;
332
:
271
6
.

4

Marchi
E
,
Vargas
FS
,
Acencio
MM
,
Sigrist
RM
,
Biscaro
MD
,
Antonangelo
L
et al.
Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions
.
Chest
2012
;
141
:
183
9
.

5

Brunelli
A
,
Charloux
A
,
Bolliger
CT
,
Rocco
G
,
Sculier
JP
,
Varela
G
et al.
European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
.
Eur Respir J
2009
;
34
:
17
41
.

6

Kouritas
VK
,
Tepetes
K
,
Christodoulides
G
,
Ioannou
M
,
Spyridakis
M
,
Gourgoulianis
KI
et al.
Permeability alterations after surgical trauma in normal rabbit peritoneum
.
Eur Surg Res
2010
;
45
:
113
9
.

7

Pischik
VG.
Technical difficulties and extending the indications for VATS lobectomy
.
J Thorac Dis
2014
;
6
:
S623
30
.

8

Li
Y
,
Wang
J
,
Yang
F
,
Liu
J
,
Li
J
,
Jiang
G
et al.
Indications for conversion of thoracoscopic to open thoracotomy in video-assisted thoracoscopic lobectomy
.
ANZ J Surg
2012
;
82
:
245
50
.

9

Watanabe
A
,
Yamauchi
A
,
Sakata
J
,
Abe
T.
Extrapleural resection of lung metastasis in a patient with dense pleural adhesions using VATS
.
Ann Thorac Surg
2001
;
71
:
2015
6
.

10

Ibrahim
M
,
Menna
C
,
Maurizi
G
,
Andreetti
C
,
D'Andrilli
A
,
Ciccone
AM
et al.
Impact of Transcollation technology in thoracic surgery: a retrospective study
.
Eur J Cardiothorac Surg
2016
;
49
:
623
6
.

11

Brunelli
A
,
Cassivi
SD
,
Halgren
L.
Risk factors for prolonged air leak after pulmonary resection
.
Thorac Surg Clin
2010
;
20
:
359
64
.

12

Rivera
C
,
Bernard
A
,
Falcoz
PE
,
Thomas
P
,
Schmidt
A
,
Bénard
S
et al.
Characterization and prediction of prolonged air leak after pulmonary resection: a nationwide study setting up the index of prolonged air leak
.
Ann Thorac Surg
2011
;
92
:
1062
8
.

13

Puri
V
,
Patel
A
,
Majumder
K
,
Bell
JM
,
Crabtree
TD
,
Krupnick
AS
et al.
Intraoperative conversion from video-assisted thoracoscopic surgery lobectomy to open thoracotomy: a study of causes and implications
.
J Thorac Cardiovasc Surg
2015
;
149
:
55
61
.

14

Augustin
F
,
Maier
HT
,
Weissenbacher
A
,
Ng
C
,
Lucciarini
P
,
Öfner
D
et al.
Causes, predictors and consequences of conversion from VATS to open lung lobectomy
.
Surg Endosc
2016
;
30
:
2415
21
.

15

Hanna
JM
,
Berry
MF
,
D'Amico
TA.
Contraindications of video-assisted thoracoscopic surgical lobectomy and determinants of conversion to open
.
J Thorac Dis
2013
;
5
:
S182
9
.

16

Samson
P
,
Guitron
J
,
Reed
MF
,
Hanseman
DJ
,
Starnes
SL.
Predictors of conversion to thoracotomy for video-assisted thoracoscopic lobectomy: a retrospective analysis and the influence of computed tomography-based calcification assessment
.
J Thorac Cardiovasc Surg
2013
;
145
:
1512
8
.

17

Kouritas
VK
,
Hatzoglou
C
,
Foroulis
CN
,
Gourgoulianis
KI.
Human parietal pleura present electrophysiology variations according to location in pleural cavity
.
Interact CardioVasc Thorac Surg
2008
;
7
:
544
7
.

18

Zühlke
HV
,
Lorenz
EM
,
Straub
EM
,
Savvas
V.
Pathophysiology and classification of adhesions
.
Langenbecks Arch Chir Verh Dtsch Ges Chir
1990
;
Suppl 2
:
1009
16
.

19

Coccolini
F
,
Ansaloni
L
,
Manfredi
R
,
Campanati
L
,
Poiasina
E
,
Bertoli
P
et al.
Peritoneal adhesions index (PAI): proposal of a score for the ‘ignored iceberg’ of medicine and surgery
.
World J Emerg Surg
2013
;
8
:
6.

20

Kouritas
VK
,
Foroulis
CN
,
Ioannou
M
,
Kalafati
G
,
Tsilimingas
N
,
Gourgoulianis
KI
et al.
Pleural electrophysiology alterations in spontaneous pneumothorax patients
.
Interact CardioVasc Thorac Surg
2010
;
10
:
958
61
.

APPENDIX. CONFERENCE DISCUSSION

Dr E. Internullo(Bristol, UK): You said your patients were classified as having or not having adhesions. How many ‘adhesions’ were adhesions? If I see just 1 cm2 of upper lobe attached to one rib and I just take it down, I might really forget the patient had any adhesions.

Dr Kouritas: Looking in the literature it is mentioned that more than 30% of adhesions of the overall area of the inner part of the chest should be considered as adhesions. However, in the whole cohort of the study, I do have data on patients having less surface coverage with adhesions, for example 10%, which suggests that if you have an inflammatory incidence in the chest cavity then that could be a problem. So that also needs to be addressed. But in this case it was >20%.

Dr R. Aparicio(Santiago, Chile): And would the strength of the adhesion make any difference? I mean those that you can just release easily down as opposed to you having to cut.

Dr Kouritas: We have looked at this as well, and we have also looked at whether you need to just take the lung down with a ‘peanut’ or use an energy device, and apparently there is a difference, but there was no time or space to present it here. Maybe in a second paper.

Author notes

Presented at the 24th European Conference on General Thoracic Surgery, Naples, Italy, 29 May–1 June 2016.